#United States #New York #Levi & Korsinsky #Baxter International

Baxter International, Inc. Faces Lawsuit

In a recent development, Baxter International, Inc., a prominent player in the healthcare sector, has found itself at the center of a class action lawsuit. The suit, initiated by Levi & Korsinsky LLP, aims to address significant concerns regarding alleged securities fraud that has reportedly impacted investors adversely. This class action covers the period between February 23, 2022, and July 30, 2025, targeting shareholders who may have suffered financial losses as a result of the company's actions during that time.

Class Definition and Allegations

The lawsuit defines a class of investors who bought shares of Baxter International during the specified timeframe. Allegations arising from the suit suggest that Baxter misled its investors by making false statements or omitting critical information regarding its recently launched product, the Novum LVP. This medical device has been linked to severe issues such as systemic defects, which have reportedly caused malfunctions like underinfusion and overinfusion of fluids. The severity of these malfunctions has raised alarms, as they expose patients to potential health hazards, including serious injuries or even death.

Specific Claims

Key claims in the lawsuit include:

• - Baxter was made aware of multiple malfunctions of the Novum LVP, leading to injuries and fatalities but failed to act adequately.
• - The company's efforts to issue customer alerts regarding these defects have been criticized as insufficient, with design flaws remaining unaddressed.
• - There exists a tangible risk that the company would have to pull existing Novum LVP devices from the market and halt future sales due to ongoing safety concerns.
• - Consequently, statements made by Baxter about the product's safety and market viability were alleged to be misleading, impacting investor decision-making.

Next Steps for Affected Investors

Investors who believe they have incurred losses as a result of Baxter's actions are urged to take immediate action. The deadline to request appointment as a lead plaintiff is December 15, 2025, though participation in the recovery does not necessitate this status. Importantly, there are no upfront costs associated with participating in this lawsuit, ensuring that affected individuals can seek restitution without financial burden.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has a robust history of advocating for shareholders, having recovered substantial amounts for clients in the past. With over 20 years of experience in complex securities litigation, the firm's proven track record includes recognition as one of the top firms in the field by ISS Securities Class Action Services. Their dedicated team of over 70 professionals stands ready to support investors navigating these challenges.

How to Get Involved

Investors looking for more information or wishing to take part in the class action can reach out directly to Levi & Korsinsky. Interested parties can visit their website or contact attorney Joseph E. Levi via phone or email for further guidance on how to proceed. This is a crucial opportunity for potentially affected investors to reclaim their losses and hold Baxter accountable for their actions.

For more information, investors can visit Levi & Korsinsky's website or contact them directly at (212) 363-7500. This could be a vital step towards justice and financial recovery for those who have been negatively impacted by these alleged securities violations.